The Global Myomectomy Market size is expected to reach $895.8 Million by 2026, rising at a market growth of 13.6% CAGR during the forecast period. Myomectomy is a medical-surgical procedure that is used in the removal of uterine fibroids. Uterine fibroids are medical conditions in which there is noncancerous growth in the uterus of females at their childbearing age, symptoms of this disease include heavy bleeding in the menstrual cycle, pain in the pelvis or lower back, more menstrual cramping, and swelling of the abdomen.
Increasing prevalence of uterine fibroids, and growing demand for diagnosis and treatment of the abdominal, urological, and uterine disorder. Moreover, increased demand for better medical devices for gynecology procedures is also fueling the growth of the market. Moreover, increasing healthcare expenditure and inclusive growth of healthcare industry is also influencing the market growth. Impressive and innovative research in the field of healthcare sectors including reproductive health is the main factor that is boosting the growth of the market. The progress of medical device industry and the growing adoption of technological advancements for developing novel medical devices also adding fuels the market growth across the globe. Though, the growth of the market is limited due to the fact that there is increasing competition among existing key players and the higher cost of these new medical devices.
Moreover, the adoption of advanced technologies and the introduction of novel products by the market players are anticipated to increase the market growth during the foreseeable period. For example, Intuitive Surgical has recently launched the Single Port Platform called “da Vinci SP Surgical System”. It allows doctors to get access to deep and narrow tissue during various urological procedures with robotic-assisted technology. As per the NCBI study report, approximately 30,000 myomectomy procedures are done annually for treating fibroids in the US. Thus, the increasing occurrence of uterine fibroids and urological problems has increased the adoption of myomectomy procedures all across the globe.
| Report Attribute | Details |
|---|---|
| Market size value in 2019 | USD 476.7 Million |
| Market size forecast in 2026 | USD 895.8 Million |
| Base Year | 2019 |
| Historical Period | 2016 to 2018 |
| Forecast Period | 2020 to 2026 |
| Revenue Growth Rate | CAGR of 13.6% from 2020 to 2026 |
| Number of Pages | 159 |
| Number of Tables | 270 |
| Report coverage | Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling |
| Segments covered | Type, Product, Region |
| Country scope | US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria |
| Growth Drivers |
|
| Restraints |
|
Free Valuable Insights: Global Myomectomy Market to reach a market size of $895.8 million by 2026
Based on Type, the market is segmented into Abdominal Myomectomy, Hysteroscopic Myomectomy and Laparoscopic Myomectomy. Based on Product, the market is segmented into Harmonic Scalpel, Laparoscopic Sealer, Laparoscopic Power Morcellators and Other Products. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.
Market Segmentation:
By Type
By Product
By Geography
Companies Profiled
The global myomectomy market size is expected to reach $895.8 Million by 2026.
Adoption of technological advanced devices for myomectomy procedures are driving the market in coming years, however, risk associated with laparoscopic power morcellators during myomectomy procedures have limited the growth of the market.
Medtronic PLC, Stryker Corporation, Johnson and Johnson, Hologic, Inc., Karl Storz SE & Co. KG, B. Braun Melsungen AG, ConMed Corporation, Intuitive Surgical, Inc., The Cooper Companies, Inc., and Minerva Surgical, Inc.
The expected CAGR of the myomectomy market is 13.6% from 2020 to 2026.
North America has the largest market of myomectomy due to the presence of main players in the healthcare IT industry in this region.
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 